CNS vs DHIL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

CNS

55.5
AI Score
VS
DHIL Wins

DHIL

63.8
AI Score

Investment Advisor Scores

CNS

56score
Recommendation
HOLD

DHIL

64score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS DHIL Winner
Forward P/E 22.9358 21.8341 DHIL
PEG Ratio 2.0481 0.5499 DHIL
Revenue Growth 12.2% -6.6% CNS
Earnings Growth 31.9% 25.5% CNS
Tradestie Score 55.5/100 63.8/100 DHIL
Profit Margin 28.8% 33.1% DHIL
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY DHIL

Relative Price Performance (Last 90 Days)

CNS 1M: +6.3% · 3M: +17.0% DHIL 1M: +1.5% · 3M: +2.9%

Current Technical Phase

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 60

RSI (14): 60.3 · Price: $82.27

DHIL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 70

RSI (14): 70.2 · Price: $174.99

Fundamentals Snapshot

Metric CNS DHIL
Market Cap
Forward P/E 21.2 21.8
Trailing P/E 25.1 9.8
Revenue (TTM)
Revenue Growth 0.1% -0.1%
Gross Margin 0.5% 0.4%
Operating Margin 0.3% 0.2%
EPS 3.25 17.92
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, DHIL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.